142 related articles for article (PubMed ID: 12789467)
41. Retinoids suppress premalignant MCF10AT but not malignant MCF10CA1a breast epithelial cells in vivo. Role of retinoic acid receptor beta2 expression.
Peng X; Wood S; Bratescu L; Shilkaitis A; Christov K
Cancer Lett; 2005 May; 222(2):153-63. PubMed ID: 15863264
[TBL] [Abstract][Full Text] [Related]
42. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.
Song S; Lippman SM; Zou Y; Ye X; Ajani JA; Xu XC
Oncogene; 2005 Dec; 24(56):8268-76. PubMed ID: 16170369
[TBL] [Abstract][Full Text] [Related]
43. An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity.
Pavan B; Dalpiaz A; Biondi C; Nieddu M; De Luca A; Prasad PD; Paganetto G; Favaloro B
Biosci Rep; 2008 Dec; 28(6):327-34. PubMed ID: 18673301
[TBL] [Abstract][Full Text] [Related]
44. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
[TBL] [Abstract][Full Text] [Related]
45. [Methylation of promoter region of RAR-beta2 gene in renal cell, breast, and ovarian carcinomas].
Khodyrev DS; Loginov VI; Pronina IV; Kazubskaia TP; Gar'kavtseva RF; Braga EA
Genetika; 2008 Aug; 44(8):1126-32. PubMed ID: 18825962
[TBL] [Abstract][Full Text] [Related]
46. Expression of retinoid receptors in sebaceous cell carcinoma.
Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
[TBL] [Abstract][Full Text] [Related]
47. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
[TBL] [Abstract][Full Text] [Related]
48. Truncated RAR beta isoform enhances proliferation and retinoid resistance.
Swift ME; Wallden B; Wayner EA; Swisshelm K
J Cell Physiol; 2006 Dec; 209(3):718-25. PubMed ID: 17001699
[TBL] [Abstract][Full Text] [Related]
49. Effect of high retinoid doses on RAR-beta mRNA expression in female B6D2F1 mice.
Johanning GL; Cope MB; Wilborn T; Grubbs CJ; Lubet RA
Anticancer Res; 2001; 21(3B):1691-5. PubMed ID: 11497248
[TBL] [Abstract][Full Text] [Related]
50. Cellular localization of retinoic acid receptor-gamma expression in normal and neoplastic skin.
Finzi E; Blake MJ; Celano P; Skouge J; Diwan R
Am J Pathol; 1992 Jun; 140(6):1463-71. PubMed ID: 1318641
[TBL] [Abstract][Full Text] [Related]
51. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
52. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
Wu K; DuPré E; Kim H; Tin-U CK; Bissonnette RP; Lamph WW; Brown PH
Breast Cancer Res Treat; 2006 Mar; 96(2):147-57. PubMed ID: 16273314
[TBL] [Abstract][Full Text] [Related]
53. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
Toulany M; Dittmann K; Baumann M; Rodemann HP
Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
[TBL] [Abstract][Full Text] [Related]
54. Running increases neurogenesis without retinoic acid receptor activation in the adult mouse dentate gyrus.
Aberg E; Perlmann T; Olson L; Brené S
Hippocampus; 2008; 18(8):785-92. PubMed ID: 18493951
[TBL] [Abstract][Full Text] [Related]
55. All-trans retinoic acid induction of sulfotransferases.
Maiti S; Chen X; Chen G
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):44-53. PubMed ID: 15667595
[TBL] [Abstract][Full Text] [Related]
56. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
57. Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis.
Marini P; Schmid A; Jendrossek V; Faltin H; Daniel PT; Budach W; Belka C
BMC Cancer; 2005 Jan; 5():5. PubMed ID: 15651986
[TBL] [Abstract][Full Text] [Related]
58. Regulation of retinoic acid receptors alpha, beta and retinoid X receptor alpha after sciatic nerve injury.
Zhelyaznik N; Mey J
Neuroscience; 2006 Sep; 141(4):1761-74. PubMed ID: 16782282
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
[TBL] [Abstract][Full Text] [Related]
60. Induction of beta-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses.
Harnish DC; Barua AB; Soprano KJ; Soprano DR
Differentiation; 1990 Nov; 45(2):103-8. PubMed ID: 1965892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
